CA3132823A1 - Systems and methods for drug-agnostic patient-specific dosing regimens - Google Patents

Systems and methods for drug-agnostic patient-specific dosing regimens Download PDF

Info

Publication number
CA3132823A1
CA3132823A1 CA3132823A CA3132823A CA3132823A1 CA 3132823 A1 CA3132823 A1 CA 3132823A1 CA 3132823 A CA3132823 A CA 3132823A CA 3132823 A CA3132823 A CA 3132823A CA 3132823 A1 CA3132823 A1 CA 3132823A1
Authority
CA
Canada
Prior art keywords
patient
drug
drugs
dosing regimen
model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3132823A
Other languages
English (en)
French (fr)
Inventor
Diane R. Mould
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2019/028750 external-priority patent/WO2019209845A1/en
Application filed by Individual filed Critical Individual
Publication of CA3132823A1 publication Critical patent/CA3132823A1/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/40ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA3132823A 2019-03-08 2020-03-09 Systems and methods for drug-agnostic patient-specific dosing regimens Pending CA3132823A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962815825P 2019-03-08 2019-03-08
US62/815,825 2019-03-08
USPCT/US2019/028750 2019-04-23
US16/391,950 2019-04-23
PCT/US2019/028750 WO2019209845A1 (en) 2018-04-23 2019-04-23 Systems and methods for modifying adaptive dosing regimens
US16/391,950 US20190326002A1 (en) 2018-04-23 2019-04-23 Systems and methods for modifying adaptive dosing regimens
PCT/US2020/021742 WO2020185699A1 (en) 2019-03-08 2020-03-09 Systems and methods for drug-agnostic patient-specific dosing regimens

Publications (1)

Publication Number Publication Date
CA3132823A1 true CA3132823A1 (en) 2020-09-17

Family

ID=72426742

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3132823A Pending CA3132823A1 (en) 2019-03-08 2020-03-09 Systems and methods for drug-agnostic patient-specific dosing regimens

Country Status (8)

Country Link
EP (1) EP3935639A1 (https=)
JP (2) JP7618239B2 (https=)
KR (1) KR102839034B1 (https=)
AU (2) AU2020239014A1 (https=)
CA (1) CA3132823A1 (https=)
IL (1) IL286145A (https=)
SG (1) SG11202109704UA (https=)
WO (1) WO2020185699A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12064664B2 (en) 2020-11-10 2024-08-20 Willowview Consulting, Llc Method and system for dynamically transforming user health and exercise-related data into visual, audio, textual, and physical data representations
US20220199266A1 (en) * 2020-12-10 2022-06-23 DataRobot, Inc. Systems and methods for using machine learning with epidemiological modeling
CN113643785B (zh) * 2021-07-22 2023-09-01 海南大学 基于dikw图谱的疫苗接种浓度确认方法
CN114765076A (zh) * 2022-04-18 2022-07-19 柳州市妇幼保健院 新生儿个体化氟康唑给药量计算方法及给药方案推荐系统
KR102834065B1 (ko) * 2022-09-22 2025-07-16 서울대학교산학협력단 약동학적 변화량 예측 장치 및 방법
CN116453669B (zh) * 2023-06-14 2023-08-25 武汉大学中南医院 一种基于大数据的护理预测方法及装置
WO2025006459A1 (en) * 2023-06-29 2025-01-02 Prxcision, Inc. Machine learning for real-time decision support
CN118016237A (zh) * 2024-01-22 2024-05-10 南栖仙策(南京)高新技术有限公司 给药剂量确定方法、装置、电子设备及存储介质
CN120448609B (zh) * 2025-07-11 2025-09-16 上海斯丹姆医药开发有限责任公司 一种流感疫苗临床试验中的数据可视化方法及系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1227302A (en) * 2000-09-15 2002-03-26 Virco Nv System and method for optimizing drug therapy for the treatment of diseases
EP2562664B1 (en) 2007-06-27 2020-11-25 Roche Diabetes Care GmbH System for determining an insulin delivery and communicating a dose in automated pancreas software
WO2011082421A1 (en) 2010-01-04 2011-07-07 Mayo Foundation For Medical Education And Research Erythropoietic stimulating agent (esa) dosage determination
JP5970449B2 (ja) 2010-04-07 2016-08-17 ノヴァディスカバリー 処置成果を予測するためのコンピュータベースシステム
SG10201907682RA (en) 2012-10-05 2019-10-30 Mould Diane System and method for providing patient-specific dosing as a function of mathematical models
CA2988724C (en) 2015-04-09 2023-10-10 Diane R. Mould Systems and methods for patient-specific dosing

Also Published As

Publication number Publication date
SG11202109704UA (en) 2021-10-28
WO2020185699A1 (en) 2020-09-17
JP7618239B2 (ja) 2025-01-21
KR20220002884A (ko) 2022-01-07
KR102839034B1 (ko) 2025-07-28
JP2022524083A (ja) 2022-04-27
IL286145A (en) 2021-10-31
JP2025020335A (ja) 2025-02-12
AU2020239014A1 (en) 2021-10-07
AU2025275175A1 (en) 2026-01-15
EP3935639A1 (en) 2022-01-12

Similar Documents

Publication Publication Date Title
US20240371491A1 (en) Systems and methods for drug-agnostic patient-specific dosing regimens
AU2024278361A1 (en) Systems and methods for modifying adaptive dosing regimens
JP7618239B2 (ja) 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法
US20230178203A1 (en) Systems and methods for patient-specific dosing
US20200143278A1 (en) Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data
JP5970449B2 (ja) 処置成果を予測するためのコンピュータベースシステム
US10262112B2 (en) Prescription decision support system and method using comprehensive multiplex drug monitoring
HK1214498A1 (zh) 药物监测与调控系统和方法
Al Faysal et al. An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals
Garces et al. Improving resource utilisation in SLE drug development through innovative trial design
US20220383991A1 (en) Systems and methods for monoclonal antibody nomograms
Rattsev et al. Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation
Birck et al. Evaluating Brazil’s national administrative claims data for real-world pharmacoepidemiologic studies: Trends in rheumatoid arthritis using DATASUS (2010–2020)
HK40079892A (en) Systems and methods for patient-specific dosing
Cai et al. RW4 DEVELOPMENT OF REAL-WORLD DATA AND THE USE OF RWD FOR EVIDENCE GENERATION IN CHINA

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240311

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250307

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250308

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250308

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250324

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250324

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250416

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250815

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250819

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20251021

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20251021